MICHELE REDELL to Treatment Outcome
This is a "connection" page, showing publications MICHELE REDELL has written about Treatment Outcome.
Connection Strength
0.018
-
Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921. J Clin Oncol. 2024 Mar 01; 42(7):821-831.
Score: 0.018